These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32724086)

  • 1. Structural insights into the activation of GLP-1R by a small molecule agonist.
    Ma H; Huang W; Wang X; Zhao L; Jiang Y; Liu F; Guo W; Sun X; Zhong W; Yuan D; Xu HE
    Cell Res; 2020 Dec; 30(12):1140-1142. PubMed ID: 32724086
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery and pharmacology of the covalent GLP-1 receptor (GLP-1R) allosteric modulator BETP: A novel tool to probe GLP-1R pharmacology.
    Willard FS; Ho JD; Sloop KW
    Adv Pharmacol; 2020; 88():173-191. PubMed ID: 32416867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide.
    Chang R; Zhang X; Qiao A; Dai A; Belousoff MJ; Tan Q; Shao L; Zhong L; Lin G; Liang YL; Ma L; Han S; Yang D; Danev R; Wang MW; Wootten D; Wu B; Sexton PM
    J Biol Chem; 2020 Jul; 295(28):9313-9325. PubMed ID: 32371397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist.
    Kawai T; Sun B; Yoshino H; Feng D; Suzuki Y; Fukazawa M; Nagao S; Wainscott DB; Showalter AD; Droz BA; Kobilka TS; Coghlan MP; Willard FS; Kawabe Y; Kobilka BK; Sloop KW
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29959-29967. PubMed ID: 33177239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptor.
    Johnson RM; Zhang X; Piper SJ; Nettleton TJ; Vandekolk TH; Langmead CJ; Danev R; Sexton PM; Wootten D
    Biochem Biophys Res Commun; 2021 Nov; 578():84-90. PubMed ID: 34547628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study.
    Redij T; Ma J; Li Z; Hua X; Li Z
    J Comput Aided Mol Des; 2019 Nov; 33(11):973-981. PubMed ID: 31758355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein.
    Zhang Y; Sun B; Feng D; Hu H; Chu M; Qu Q; Tarrasch JT; Li S; Sun Kobilka T; Kobilka BK; Skiniotis G
    Nature; 2017 Jun; 546(7657):248-253. PubMed ID: 28538729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of peptidomimetic agonism revealed by small- molecule GLP-1R agonists Boc5 and WB4-24.
    Cong Z; Zhou Q; Li Y; Chen LN; Zhang ZC; Liang A; Liu Q; Wu X; Dai A; Xia T; Wu W; Zhang Y; Yang D; Wang MW
    Proc Natl Acad Sci U S A; 2022 May; 119(20):e2200155119. PubMed ID: 35561211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics.
    Gómez Santiago C; Paci E; Donnelly D
    Biochem Biophys Res Commun; 2018 Mar; 498(2):359-365. PubMed ID: 29397068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex.
    Liang YL; Khoshouei M; Glukhova A; Furness SGB; Zhao P; Clydesdale L; Koole C; Truong TT; Thal DM; Lei S; Radjainia M; Danev R; Baumeister W; Wang MW; Miller LJ; Christopoulos A; Sexton PM; Wootten D
    Nature; 2018 Mar; 555(7694):121-125. PubMed ID: 29466332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
    J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism.
    Lei S; Clydesdale L; Dai A; Cai X; Feng Y; Yang D; Liang YL; Koole C; Zhao P; Coudrat T; Christopoulos A; Wang MW; Wootten D; Sexton PM
    J Biol Chem; 2018 Jun; 293(24):9370-9387. PubMed ID: 29717000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery.
    Harikumar KG; Wootten D; Pinon DI; Koole C; Ball AM; Furness SG; Graham B; Dong M; Christopoulos A; Miller LJ; Sexton PM
    Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18607-12. PubMed ID: 23091034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Landmark studies on the glucagon subfamily of GPCRs: from small molecule modulators to a crystal structure.
    Yang DH; Zhou CH; Liu Q; Wang MW
    Acta Pharmacol Sin; 2015 Sep; 36(9):1033-42. PubMed ID: 26279155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists.
    Zhang X; Belousoff MJ; Zhao P; Kooistra AJ; Truong TT; Ang SY; Underwood CR; Egebjerg T; Šenel P; Stewart GD; Liang YL; Glukhova A; Venugopal H; Christopoulos A; Furness SGB; Miller LJ; Reedtz-Runge S; Langmead CJ; Gloriam DE; Danev R; Sexton PM; Wootten D
    Mol Cell; 2020 Nov; 80(3):485-500.e7. PubMed ID: 33027691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insights into the dynamics behavior of glucagon-like peptide-1 receptor with its small molecule agonists.
    Girdhar K; Dehury B; Kumar Singh M; Daniel VP; Choubey A; Dogra S; Kumar S; Mondal P
    J Biomol Struct Dyn; 2019 Sep; 37(15):3976-3986. PubMed ID: 30296922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane α-helix 2 and 7 are important for small molecule-mediated activation of the GLP-1 receptor.
    Rye Underwood C; Møller Knudsen S; Schjellerup Wulff B; Bräuner-Osborne H; Lau J; Knudsen LB; Peters GH; Reedtz-Runge S
    Pharmacology; 2011; 88(5-6):340-8. PubMed ID: 22134089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling.
    Dods RL; Donnelly D
    Biosci Rep; 2015 Nov; 36(1):e00285. PubMed ID: 26598711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor.
    Cong Z; Chen LN; Ma H; Zhou Q; Zou X; Ye C; Dai A; Liu Q; Huang W; Sun X; Wang X; Xu P; Zhao L; Xia T; Zhong W; Yang D; Eric Xu H; Zhang Y; Wang MW
    Nat Commun; 2021 Jun; 12(1):3763. PubMed ID: 34145245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.
    Hou Y; Ernst SA; Heidenreich K; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G26-33. PubMed ID: 26542397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.